A Real World Study Assessing the Safety and Effectiveness of Secukinumab in Patients with Plaque-Psoriasis and Psoriatic-Arthritis

Trial Profile

A Real World Study Assessing the Safety and Effectiveness of Secukinumab in Patients with Plaque-Psoriasis and Psoriatic-Arthritis

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2017

At a glance

  • Drugs Secukinumab (Primary)
  • Indications Plaque psoriasis; Psoriatic arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Jun 2017 New trial record
    • 07 Mar 2017 Trial design presented at the 75th Annual Meeting of the American Academy of Dermatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top